New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment
Por um escritor misterioso
Descrição
In a recent article published in Clinical Microbiology and Infection, researchers reviewed all registered trials currently investigating potential treatment options for post-acute coronavirus disease 2019 (COVID-19) syndrome (PACS).
NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment
Frontiers Psychophysical therapy and underlying neuroendocrine mechanisms for the rehabilitation of long COVID-19
A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 - eClinicalMedicine
Worldwide Survey of COVID-19–Associated Arrhythmias
Clinical Trials – Medisys Research
Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases - ScienceDirect
Long COVID and its Management
Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study
Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event - Journal of Cardiac Failure
IJMS, Free Full-Text
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
Post-acute COVID-19 syndrome and kidney diseases: what do we know?
Frontiers Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
de
por adulto (o preço varia de acordo com o tamanho do grupo)